Duke Alumnus Receives Marshall Scholarship for Graduate Study in the United Kingdom
Currently at the National Institutes of Health, Glasstetter is working to discover new small-
molecule therapeutics for two protein-misfolding diseases: Parkinson’s disease, a common neurodegenerative disease, and Gaucher disease, a rare lysosomal storage disorder.
“Logan is an exceptional student and scientist who distinguished himself through his undergraduate research in two Duke faculty labs, and is motivated to pursue a career in medical science for the benefit of others,” said Duke President Vincent E. Price. “I am delighted he has been selected as a Marshall Scholar and will have the opportunity to continue his studies in the United Kingdom.”
As a Marshall Scholar, Glasstetter will pursue a master’s degree in drug discovery and development at the University of Leeds and a master’s in chemistry at the University of Cambridge.
He plans to become a physician-scientist in the field of drug discovery and development, producing novel therapies for difficult-to-treat protein-misfolding diseases. In the UK, he plans to study these diseases, which include Parkinson’s disease, Alzheimer’s disease, and Type 2 diabetes, by training under internationally renowned experts focusing on structure-based drug discovery.
Duke students and alumni can receive support for opportunities like the Marshall Scholarship from the Nationally Competitive Scholarships team at the Office of University Scholars and Fellows.